Sevinç Jakab (Sevinç Gücüm)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Topics

Transcription Factor

Endovascular Treatment

Small Cell Lung Cancer

Top Venues

Development (Cambridge, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Moritz Jakab, Ki Hong Lee, Alexey Uvarovskii, Svetlana Ovchinnikova, Shubhada R Kulkarni, Sevinç Jakab, Till Rostalski, Carleen Spegg, Simon Anders, Hellmut G Augustin
Lung endothelium exploits susceptible tumor cell states to instruct metastatic latency. Nature cancer (2024)
Moritz Jakab, Ki Hong Lee, Alexey Uvarovskii, Svetlana Ovchinnikova, Shubhada R Kulkarni, Sevinç Jakab, Till Rostalski, Carleen Spegg, Simon Anders, Hellmut G Augustin
Lung endothelium exploits susceptible tumor cell states to instruct metastatic latency. Nature cancer 5 (5) (2024)
Moritz Jakab, Ki Hong Lee, Alexey Uvarovskii, Svetlana Ovchinnikova, Shubhada R Kulkarni, Sevinç Jakab, Till Rostalski, Carleen Spegg, Simon Anders, Hellmut G Augustin
Lung endothelium exploits susceptible tumor cell states to instruct metastatic latency. Nature cancer 5 (5) (2024)
Moritz Jakab, Ki Hong Lee, Alexey Uvarovskii, Svetlana Ovchinnikova, Shubhada R Kulkarni, Sevinç Jakab, Till Rostalski, Carleen Spegg, Simon Anders, Hellmut G Augustin
Lung endothelium exploits susceptible tumor cell states to instruct metastatic latency. Nature cancer 5 (5) (2024)
Sevinç Jakab, Roman Sakson, Marcus Hoffmann, Valerian Grote, Clara Becker, Kaisa Pakari, Lars Beedgen, Christian Thiel, Erdmann Rapp, Thomas Ruppert, Thomas Thumberger, Joachim Wittbrodt
A patient-based medaka alg2 mutant as a model for hypo-N-glycosylation. Development (Cambridge, England) 148 (11) (2021)